38519009|t|Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias.
38519009|a|BACKGROUND: To determine whether Lewy body dementia (LBD) patients with likely copathology of Alzheimer's disease (AD) exhibit greater neuropsychiatric symptom (NPS) compared to those without likely AD-type copathology. METHODS: We enrolled 69 individuals diagnosed with Lewy body dementia (LBD), comprising both dementia with Lewy bodies (DLB) (n = 36) and Parkinson's disease dementia (PDD) (n = 33). These participants had accessible cerebrospinal fluid (CSF) markers related to Alzheimer's disease (AD) and cognitive data. We assessed CSF levels of beta-amyloid 42 (Abeta42), phosphorylated tau (p-tau), and total tau (t-tau). Employing autopsy-validated CSF thresholds (t-tau/Abeta42 ratio > 0.3, n = 69), we categorized individuals into LBD with AD pathology (LBD + AD, n = 31) and LBD without apparent AD co-pathology (LBD - AD, n = 38). Moreover, the Hamilton Depression Scale (HAMD24), Hamilton Anxiety Scale (HAMA14), and Neuropsychiatric Inventory Questionnaire (NPI-Q) was used to assess the NPS. Spearman correlations were utilized to explore links between NPS and CSF marker profiles. RESULTS: In terms of neuropsychiatric symptoms, LBD + AD patients demonstrated notably elevated levels of depressive symptoms (HAMD24) in comparison to LBD - AD patients (P < 0.001). However, based on PDD and DLB groups, no significant variations were noted in the neuropsychiatric symptoms(P>0.05). Moreover, CSF-derived biomarkers of Abeta42, and t-tau/Abeta42 were also associated with HAMD24 total scores in the LBD + AD subsample (P < 0.05). CONCLUSION: There is an association between AD pathological markers and the NPS of LBD. The biologically based classification of LBD may be more advantageous in elucidating clinical heterogeneity than clinically defined syndromes.
38519009	0	25	Neuropsychiatric symptoms	Disease	MESH:D001523
38519009	49	66	Alzheimer disease	Disease	MESH:D000544
38519009	85	93	patients	Species	9606
38519009	99	118	Lewy body dementias	Disease	MESH:D020961
38519009	153	171	Lewy body dementia	Disease	MESH:D020961
38519009	173	176	LBD	Disease	MESH:D020961
38519009	178	186	patients	Species	9606
38519009	214	233	Alzheimer's disease	Disease	MESH:D000544
38519009	235	237	AD	Disease	MESH:D000544
38519009	255	279	neuropsychiatric symptom	Disease	MESH:D001523
38519009	281	284	NPS	Disease	MESH:D001523
38519009	319	321	AD	Disease	MESH:D000544
38519009	391	409	Lewy body dementia	Disease	MESH:D020961
38519009	411	414	LBD	Disease	MESH:D020961
38519009	433	458	dementia with Lewy bodies	Disease	MESH:D020961
38519009	460	463	DLB	Disease	MESH:D020961
38519009	478	506	Parkinson's disease dementia	Disease	MESH:D010300
38519009	508	511	PDD	Disease	MESH:D010300
38519009	602	621	Alzheimer's disease	Disease	MESH:D000544
38519009	623	625	AD	Disease	MESH:D000544
38519009	690	697	Abeta42	Gene	351
38519009	715	718	tau	Gene	4137
38519009	722	725	tau	Gene	4137
38519009	738	741	tau	Gene	4137
38519009	745	748	tau	Gene	4137
38519009	797	800	tau	Gene	4137
38519009	801	808	Abeta42	Gene	351
38519009	863	866	LBD	Disease	MESH:D020961
38519009	872	874	AD	Disease	MESH:D000544
38519009	886	889	LBD	Disease	MESH:D020961
38519009	892	894	AD	Disease	MESH:D000544
38519009	908	911	LBD	Disease	MESH:D020961
38519009	929	931	AD	Disease	MESH:D000544
38519009	946	949	LBD	Disease	MESH:D020961
38519009	952	954	AD	Disease	MESH:D000544
38519009	988	998	Depression	Disease	MESH:D003866
38519009	1024	1031	Anxiety	Disease	MESH:D001007
38519009	1124	1127	NPS	Disease	MESH:D001523
38519009	1190	1193	NPS	Disease	MESH:D001523
38519009	1240	1265	neuropsychiatric symptoms	Disease	MESH:D001523
38519009	1267	1270	LBD	Disease	MESH:D020961
38519009	1273	1275	AD	Disease	MESH:D000544
38519009	1276	1284	patients	Species	9606
38519009	1325	1344	depressive symptoms	Disease	MESH:D003866
38519009	1371	1374	LBD	Disease	MESH:D020961
38519009	1377	1379	AD	Disease	MESH:D000544
38519009	1380	1388	patients	Species	9606
38519009	1420	1423	PDD	Disease	MESH:D010300
38519009	1428	1431	DLB	Disease	MESH:D020961
38519009	1484	1509	neuropsychiatric symptoms	Disease	MESH:D001523
38519009	1555	1562	Abeta42	Gene	351
38519009	1570	1573	tau	Gene	4137
38519009	1574	1581	Abeta42	Gene	351
38519009	1635	1638	LBD	Disease	MESH:D020961
38519009	1641	1643	AD	Disease	MESH:D000544
38519009	1710	1712	AD	Disease	MESH:D000544
38519009	1742	1745	NPS	Disease	MESH:D001523
38519009	1749	1752	LBD	Disease	MESH:D020961
38519009	1795	1798	LBD	Disease	MESH:D020961
38519009	Association	MESH:D001523	351

